Aycha J. Bleeker
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Hepatocyte-specific Cas9-mediated editing of G6pc and Slc37a4 elicits comparable biochemical and regulatory responses between glycogen storage disease (GSD) type Ia and Ib mice.
Journal: Molecular metabolism
Published: October 24, 2025
Untargeted Proteomics Profiling of Liver and Plasma in Fed and Fasted Liver-Specific Glycogen Storage Disease Type Ia (GSD Ia) Mice: Toward Potential Protein Biomarkers.
Journal: Journal of inherited metabolic disease
Published: April 24, 2025
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 04, 2023
Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia.
Journal: Cancer & metabolism
Published: January 25, 2023
Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.
Journal: Journal of inherited metabolic disease
Published: September 07, 2020
Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Journal: Hepatology (Baltimore, Md.)
Published: July 05, 2019
Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
Journal: Nanotoxicology
Published: September 06, 2018
Glucose-6-Phosphate Regulates Hepatic Bile Acid Synthesis in Mice.
Journal: Hepatology (Baltimore, Md.)
Published: August 27, 2018
Last Updated: 09/26/2026